Phibro Animal Health (PAHC) Non-Current Deferred Tax Liability (2019 - 2022)
Phibro Animal Health (PAHC) recorded quarterly Non-Current Deferred Tax Liability of $8.8 million in Q1 2022, up 9.72% quarter-over-quarter from $8.1 million in Q4 2021, and down 28.45% on a YoY basis from $12.4 million in Q1 2021.
Phibro Animal Health (PAHC) Non-Current Deferred Tax Liability (2019 - 2022) Analysis & Trends
Phibro Animal Health's Non-Current Deferred Tax Liability history runs 4 years deep, the most recent figure standing at $8.8 million for Q1 2022.
- In Q1 2022, Non-Current Deferred Tax Liability fell 28.45% year-over-year to $8.8 million; the TTM figure through Mar 2022 stood at $8.8 million (down 28.45% YoY), while the FY2021 annual figure was $6.6 million, up 451.54% from the prior year.
- Non-Current Deferred Tax Liability was $8.8 million for Q1 2022 at Phibro Animal Health, up from $8.1 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $12.4 million in Q1 2021 to a low of $1.2 million in Q2 2020.
- Historically, Non-Current Deferred Tax Liability has averaged $7.8 million across 4 years, with a median of $8.8 million in 2022.
- The sharpest annual moves came in 2020 and 2021: Non-Current Deferred Tax Liability slumped 36.07% in 2020, then soared 451.54% in 2021.
- A 4-year view of Non-Current Deferred Tax Liability shows it stood at $9.5 million in 2019, then climbed by 26.6% to $12.1 million in 2020, then plunged by 33.09% to $8.1 million in 2021, then gained by 9.72% to $8.8 million in 2022.
- The last three Non-Current Deferred Tax Liability figures came in at $8.8 million (Q1 2022), $8.1 million (Q4 2021), and $7.3 million (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 8.85 Mn |
| Mar 31, 2022 | 8.85 Mn |
| Dec 31, 2021 | 8.06 Mn |
| Dec 31, 2021 | 8.06 Mn |
| Sep 30, 2021 | 7.30 Mn |
| Sep 30, 2021 | 7.30 Mn |
| Jun 30, 2021 | 6.65 Mn |
| Jun 30, 2021 | 6.65 Mn |
| Mar 31, 2021 | 12.37 Mn |
| Mar 31, 2021 | 12.37 Mn |
| Dec 31, 2020 | 12.05 Mn |
| Dec 31, 2020 | 12.05 Mn |
| Jun 30, 2020 | 1.21 Mn |
| Jun 30, 2020 | 1.21 Mn |
| Mar 31, 2020 | 9.29 Mn |
| Mar 31, 2020 | 9.29 Mn |
| Dec 31, 2019 | 9.52 Mn |
| Dec 31, 2019 | 9.52 Mn |
| Sep 30, 2019 | 9.02 Mn |
| Sep 30, 2019 | 9.02 Mn |